Skip to main content
Fig. 2 | Allergy, Asthma & Clinical Immunology

Fig. 2

From: Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy

Fig. 2

Patient opinions and experience with C1INH(SC) replacement therapy. Concepts and themes that emerged from 5 or more patient interviews out of N = 14 total interviews. HAE hereditary angioedema, C1INH(SC) subcutaneous C1 inhibitor

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us